G. Delling

Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

M. Schulte, D. Brecht‐Krauss, Mathias Werner et al. · PubMed · 1999 · 205 citations

The origin of the neoplastic stromal cell in giant cell tumor of bone1 1All figures in this article may be viewed in color on the University of Hamburg-Eppendorf web site at http://www.uke.uni-hamburg.de/zentren/klinisch-theoretische_medzin_1/osteopathologie/patho/index.html.

Manuela Wülling, G. Delling, Edelgard Kaiser · Human Pathology · 2003 · 148 citations

Tumoral Pathology, Hamburg-eppendorf Web Site, Bone Morphogenic Protein +10

Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)

K. Winkler, Stefan Bielack, G. Delling et al. · Cancer · 1990 · 148 citations

Prognostic significance of drug-regulated genes in high-grade osteosarcoma

Jörg Fellenberg, Ludger Bernd, G. Delling et al. · Modern Pathology · 2007 · 141 citations

Tumor Biology, Medicine, Pathology +4

Architecture and distribution of cancellous bone yield vertebral fracture clues

Michael Amling, M. P�sl, H. Ritzel et al. · Archives of Orthopaedic and Trauma Surgery · 1996 · 75 citations

Skeletal Trauma, Axial Skeleton, Bone Imaging +5